AtaiBeckley Inc. (NASDAQ: ATAI) announced plans to initiate two parallel Phase 3 studies for BPL-003, a nasal spray treatment for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE